Methylene Blue and Ozone in Early Sepsis
NCT02910765 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2016-09-22
Summary
effects of methylene blue and ozone O3 therapy effects in early sepsis management , and their implications upon outcome
Conditions
Interventions
- DRUG
-
methylene blue
- DRUG
-
ozone
- OTHER
-
saline infusion
- OTHER
-
oxygen
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Emad Zarief K Said, MD · Assiut University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-10-31
- Primary Completion
- 2017-03-31
- Completion
- 2017-04-30
More Related Trials
-
Methylene Blue in Sepsis: A Randomized Controlled Trial
NCT00486174 ·Status: WITHDRAWN ·Phase: NA
-
Methylene Blue and Microcirculation in Septic Shock
NCT04295993 ·Status: UNKNOWN ·Phase: PHASE3
-
Methylene Blue for the Treatment of Septic Shock
NCT06532240 ·Status: COMPLETED ·Phase: PHASE3
-
Prolonged Intravenous Infusion of β-lactam Antibiotics in Early Septic Patients
NCT05024565 ·Status: UNKNOWN ·Phase: NA
-
Immunomodulatory Properties of Ketamine in Sepsis
NCT01089361 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock
NCT01867905 ·Status: COMPLETED
-
Adjunctive Methylene Blue in Septic Shock
NCT06900140 ·Status: COMPLETED ·Phase: PHASE3
-
Early Procalcitonin Kinetics During Empirical Antibiotic Therapy in Critically Ill Patients
NCT02294695 ·Status: COMPLETED
-
Sensitivity and Specificity of Leucocytes Profiling Versus Platelet Indices in Prediction of Clinical Outcome for Candidates With Sepsis. A Bi-centric Observational Clinical Trial
NCT06612307 ·Status: COMPLETED
-
The Role of Myristic Acid in Serum for Early Diagnosis of Sepsis and Comparison With Selected Biomarkers of Sepsis
NCT03314831 ·Status: COMPLETED
-
The Effect of High Dose Parenteral Ascorbic Acid On Microcirculation In Sepsis
NCT04773717 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial of Procalcitonin-guided Antimicrobial Therapy in Sepsis
NCT03333304 ·Status: COMPLETED ·Phase: NA
-
Early Use of Polymyxin B Hemoperfusion in Abdominal Sepsis
NCT00629382 ·Status: COMPLETED ·Phase: PHASE4
-
Physician Administered Antibiotics in a Prehospital Setting
NCT03919851 ·Status: COMPLETED
-
Metabolism of Branched-chain Amino Acids in Monocyte/Macrophage During Sepsis
NCT03842371 ·Status: UNKNOWN
-
Pharmacokinetics, Safety, Tolerability and Pharmacodynamics of BMS-986189 in Healthy Subjects
NCT02739373 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Trial of External Warming in Septic Patients
NCT02706275 ·Status: COMPLETED ·Phase: NA
-
Impact of 30 mg/kg Amikacin and 8 mg/kg Gentamicin on Serum Concentrations in Critically Ill Patients With Severe Sepsis
NCT02898961 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized Trial of Inhaled Nitric Oxide to Augment Tissue Perfusion in Sepsis
NCT00608322 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Moderate-Dose Steroid Therapy in Sepsis
NCT01275638 ·Status: COMPLETED ·Phase: PHASE4
-
Use of Procalcitonin, a Blood Test to Guide Antibiotic Therapy for Sepsis in Adults
NCT05955612 ·Status: COMPLETED ·Phase: PHASE3
-
Interest of the Balance of Pro-coagulating and Profibrinolytis Activities of the Microparticles (MP) in the Prognosis of Septic Shock
NCT02062970 ·Status: UNKNOWN ·Phase: NA
-
Utility of Presepsin in Distinguishing Between Sepsis and SIRS
NCT02052895 ·Status: COMPLETED
-
Procalcitonin Monitoring May Decrease Antibiotic Use in the Intensive Care Unit
NCT01085994 ·Status: UNKNOWN
-
A STUDY BEFORE/AFTER THE IMPLEMENTATION OF AN ANTI-INFECTIOUS PRESCRIPTION AID
NCT05140213 ·Status: COMPLETED